CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-03 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −128 | $227.68 | $29K | 3,296 |
| 2023-02-03 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −185 | $230.20 | $43K | 3,111 |
| 2023-02-03 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −865 | $231.35 | $200K | 2,246 |
| 2023-02-03 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −1,293 | $232.53 | $301K | 953 |
| 2023-02-03 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −953 | $233.31 | $222K | 0 |
| 2023-02-02 | Franchini Indrani Lall EVP, CLO & Secretary | Sale | −77 | $223.97 | $17K | 5,098 |
| 2023-02-02 | Franchini Indrani Lall EVP, CLO & Secretary | Sale | −1,007 | $225.80 | $227K | 4,091 |
| 2023-02-02 | Franchini Indrani Lall EVP, CLO & Secretary | Sale | −586 | $226.62 | $133K | 3,505 |
| 2023-02-02 | Franchini Indrani Lall EVP, CLO & Secretary | Sale | −5 | $227.38 | $1K | 3,500 |
| 2023-02-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −73 | $223.97 | $16K | 4,952 |
| 2023-02-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −963 | $225.80 | $217K | 3,989 |
| 2023-02-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −561 | $226.62 | $127K | 3,428 |
| 2023-02-02 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −4 | $227.38 | $910 | 3,424 |
| 2023-02-01 | Franchini Indrani Lall EVP, CLO & Secretary | Exercise or conversion | +5,175 | 5,175 | ||
| 2023-02-01 | Franchini Indrani Lall EVP, CLO & Secretary | Exercise or conversion · Restricted Stock Units | −5,175 | 10,350 | ||
| 2023-02-01 | Tanguler Tolga EVP, Chief Commercial Officer | Exercise or conversion | +5,025 | 5,025 | ||
| 2023-02-01 | Tanguler Tolga EVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −5,025 | 0 | ||
| 2023-01-05 | Bertozzi Carolyn R Director | Grant or award · Stock Option (right to buy) | +4,268 | 4,268 | ||
| 2022-12-05 | Vaishnaw Akshay President | Exercise or conversion | +1,124 | $88.95 | $100K | 19,470 |
| 2022-12-05 | Vaishnaw Akshay President | Exercise or conversion | +1,587 | $63.00 | $100K | 21,057 |
Page 58 of 63 · 1,253 trades